Doing Less Can Be Doing More for Healthcare – the Biggest Takeaway From ASCO 2018
Health Populi
JUNE 5, 2018
Groundbreaking research presented at this week’s ASCO meeting found that some women diagnosed with certain forms of cancer do not benefit from undergoing chemotherapy. ” A genetic test that costs $3,000 helps to identify women who could benefit from avoiding chemo. The test is called the Oncotype DX Breast Recurrence Score.
217 
Let's personalize your content